Filing Details

Accession Number:
0001104659-14-040582
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-21 08:51:15
Reporting Period:
2014-05-20
Filing Date:
2014-05-21
Accepted Time:
2014-05-21 08:51:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1526119 Verastem Inc. VSTM Pharmaceutical Preparations (2834) 273269467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1185039 Richard Aldrich C/O Verastem, Inc.,
215 First Street, Suite 440
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-20 1,000 $8.37 408,142 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,000 Indirect By Richard H. Aldrich 2005 Revocable Trust
Common Stock 26 Indirect By Longwood Fund, L.P.
Common Stock 143,554 Indirect By Longwood Fund GP, LLC
Common Stock 135,714 Indirect By Richard H. Aldrich Irrevocable Trust of 2011
Footnotes
  1. Reflects change in beneficial ownership pursuant to the partnership agreement of Longwood Fund, L.P.
  2. Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose.
  3. Reflects change in beneficial ownership pursuant to the partnership agreement of Longwood Fund, L.P.
  4. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund GP, LLC (the "Longwood GP Shares"). Each of the Managers disclaims beneficial ownership of the Longwood GP Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood GP Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood GP Shares for purposes of Section 16 or for any other purpose.